Authors
Latest:
Potential Impact of Emerging PPF Treatments on Patient Outcomes and Health Ccare Resource UtilizationPanelists discuss the potential role of emerging treatments in the progressive pulmonary fibrosis (PPF) landscape if approved, exploring how they could address key unmet needs, improve patient outcomes, and optimize healthcare resource utilization.
Latest:
How COVID-19 Has Revealed Cracks in the Mental Health Support System for Healthcare WorkersManagers can help by removing any stigma against seeking help and providing access to support groups and professional services.
Latest:
Opdivo-Chemo Combo Before Surgery Improves Long-Term Lung Cancer Survival, Pivotal Trial FindsFindings mark the first time a neoadjuvant immunotherapy regimen has demonstrated a significant survival benefit in a randomized phase 3 trial of a solid tumor.
Latest:
The Well-being Measurement ProblemSurveys are important, but respondents may hide their true thoughts and feelings.
Latest:
Profits of Publicly Traded Health Plans Surge Amid Requests for Higher RatesAmid struggling providers, furloughs of essential workers, years of premium increases and record high earnings, for-profit health plans should consider options for directly helping their networks.
Latest:
Key Takeaways for Managed Care Organizations as No Surprises Act Goes Into EffectThe No Surprises Act is scheduled to go into effect in January. The law will require providers to provide patients with details of the new balance billing requirements, any state-level limitations or prohibitions in the state of service, and the dispute resolution process.
Latest:
Potential Urology Drug Savings Through Mark Cuban Drug CompanyThe greatest savings are seen for 90-tablet prescriptions.
Latest:
Transforming Healthcare Workforce for Future ChallengesDiscover how healthcare is evolving, the workforce hurdles it faces, and the game-changing role of technology in overcoming these obstacles.
Latest:
Lung Cancer Drugs Shows Promise for Treatment-Resistant MelanomaEGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a specific mutation that can lead to resistance to immunotherapy.
Latest:
Unlocking Better Health: Why Health Literacy Needs a Digital RevolutionArtificial intelligence stands out as a particularly promising solution to the challenges of improving health literacy.
Latest:
Embracing AI Wisely: A Health Plan Leader’s Guide to Benefits, Risks, and ReadinessThe authors provide a detailed framework for assessing the adoption of artificial intelligence.
Latest:
The Future of Care Demands a Virtual Health EcosystemAreas of focus in the virtual health ecosystem.
Latest:
Strategies to Help Health Plans Prepare for Risk Adjustment, Star Ratings ChangesOne of the changes that CMS has added is a Health Equity Index (HEI) reward to its Stars program. The agency will use HEI data collected this year and next to calculate 2027 Star Ratings, so plans must capture member data on every measure included in the HEI.
Latest:
As Boundaries of Specialty Pharmacy Change, So Must Patient Support Services | Asembia AXS25Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium on leveraging artificial intelligence, technology and cross-functional expertise to create more personalized, efficient patient support services.
Latest:
Patient Engagement: A Key Element for Success in Value-Based CareTo support a value-based care model, healthcare organizations should focus on creating meaningful engagement throughout the patient's journey. This includes contacting patients at the right time through the right channel with relevant messages.
Latest:
The Impact of Vaccines on Long CovidResearch suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.
Latest:
CAR T-cell Therapy Shows 6-Year Durability in CLL PatientsA study suggests that a novel CAR T-cell therapy could be a curative treatment for some patients with chronic lymphocytic leukemia, with 25% of responders still in remission after 6 years.
Latest:
Shifting to an Endemic: How Tech Will Enable Greater Access to Affordable HealthcareThere are three key facets that must be considered in order to meet the demands of an endemic - the ongoing acceptance of a baseline of COVID-19 infection rates that will be maintained for the foreseeable future.
Latest:
The Economic Impact of ADPKD on Patients, PayersWhile physical and mental effects of Autosomal Dominant Polycystic Kidney Disease are top of mind for those personally impacted, as well as for nephrologists, the financial implications associated with this condition are often overlooked despite the fact that research has confirmed the economic burden of the disease increases over time for both the patient and the healthcare system.
Latest:
SkinCure Oncology Secures Patent for Innovative Image-Guided Technology in Nonmelanoma Skin Cancer TreatmentSkinCure Oncology has not yet submitted its data to the FDA for marketing clearance, however once cleared, the new devices will use hybrid laser-generated confocal and photoacoustic imaging in a single fused volumetric image.
Latest:
Simulacra of Data as an Answer | Predictions for 2025A prediction for the year by Brandi Meyers, vice president of Revenue Operations at MDClone.
Latest:
Fixed-Ratio Combinations for Type 2 DiabetesDr Jennifer Brigitte Green considers the patient selection for fixed-ratio combinations of basal insulin and GLP-1 receptor agonists among patients with type 2 diabetes and provides insight around Medicare patient access to insulin and injectable medications.
Latest:
Price Transparency Reveals Multiple Dimensions of Healthcare Inequities Beyond Just PatientsPricing data shows that doctors serving these communities facing economic challenges are paid less by insurers, effectively penalizing doctors for working in areas where people most need their care.
Latest:
Innovation or illusion? Evaluating CVS's CostVantage strategyWhile CVS argues that its CostVantage model will provide more transparency and clarity in the pricing of drugs, there is no accompanying statement that this will lower drug prices.
Latest:
Reinventing the Healthcare Workplace: Futurizing the Operating Model for Human Capital ManagementMany leaders in healthcare would agree the healthcare sector has been operating in crisis mode for more than two straight years.
Latest:
Artificial Intelligence and Dental Claims Review: A More Predictable Consumer ExperienceArtificial Intelligence in dentistry and dental benefits will lead to a shared understanding between consumers, dentists and insurers.
